Share:
Share this content in WeChat
X
Experience Exchanges
Evaluation of PI-RADS V2 in diagnosis of prostate cancer by using 3.0 T MR
LI Peng  HUANG Yun-hai  ZHANG Jin  JING Jing 

DOI:10.12015/issn.1674-8034.2018.10.011.


[Abstract] Objective: To explore the diagnostic value of prostate image report and data system version 2 (PI-RADS V2) score in the diagnosis of prostate cancer (Pca) by 3.0 T MRI and body coil.Materials and Methods: The mutli-parameter magnetic resonance imaging (Mp-MRI) and clinical data of 50 patients with Pca confirmed by pathology were retrospectively analyzed. The prostate was divided into 6 parts according to the cutting model. Two doctors evaluated the effective predefined partitions of the Mp-MRI prostate images, compared the scores of each partition with the corresponding pathological results of the subarea, analyzed the uniformity and diagnostic results. The sensitivity, specificity, accuracy, positive predictive value and negative predictive value were evaluated.Results: 50 cases were divided into 300 prostatic central glandular regions, of which 238 were effectively predefined, the results were consistent well. The results showed that when the PI-RADS V2 score was 4, the diagnostic accuracy was 79.2%, the sensitivity was 70.4%, and the specificity was 83.8%. Routine reading results: the accuracy was 72.7%, the sensitivity was 49.7%, and the specificity was 92.3%.Conclusions: The diagnostic accuracy of PI-RADS V2 is high, and the results are highly consistent. The diagnostic efficiency of PI-RADS V2 in diagnosing central adenocarcinoma of prostate is better than that of routine reading.
[Keywords] Prostatic neoplasms;Magnetic resonance imaging;Prostate image report and data system Version 2

LI Peng Department of CT/MR, the Forth People’s Hospital, Changzhou 213000, China

HUANG Yun-hai* Department of CT/MR, the Forth People’s Hospital, Changzhou 213000, China

ZHANG Jin Department of CT/MR, the Forth People’s Hospital, Changzhou 213000, China

JING Jing Department of CT/MR, the Forth People’s Hospital, Changzhou 213000, China

*Correspondence to: Huang YH, E-mail: hyhhjn@sina.com

Conflicts of interest   None.

Received  2018-05-04
DOI: 10.12015/issn.1674-8034.2018.10.011
DOI:10.12015/issn.1674-8034.2018.10.011.

[1]
靳风烁,梁培平,张克勤,等.中国前列腺癌诊疗指南.北京:人民军医出版社, 2008: 104-107.
[2]
Barrett T, Turkbey B, Choyke PL. PI-RADS Version 2: What you need to know. Clin Radiol, 2015, 70(11): 1165-1176.
[3]
陈烨,亓培君,鹿皎,等.经直肠超声引导前列腺"10+X"点穿刺活检术的临床价值.徐州医学院学报, 2014, 34(7): 54-56.
[4]
Barentsz JO, Richenberg J, Clements R, et al. ESUR prostate MR guidelines 2012. Eur Radiol, 2012, 22(5): 46-57.
[5]
张配配,王良. PI-RADS相关的前列腺癌热点问题研究现状.影像诊断与介入放射学, 2017, 26(6): 496-503.
[6]
Moritz KS, Lehmann T, Aschenbach R, et al. Assessment of PI-RADS v2 for the detection of prostate cancer. Eur J Radiol, 2016, 85(4): 137-145.
[7]
曾浩,杨国庆,付泉水,等.基于PI-RADS v2研究多参数磁共振成像在前列腺癌中的诊断价值.中国临床医学影像杂志, 2017, 28(1): 60-63.
[8]
胡毅,许梓童,杨海鹏,等.应用PI-RADS version 2诊断前列腺癌在基层医院的应用价值.中国CT和MRI杂志, 2018, 16(2): 24-25.
[9]
Barentsz JO, Weinreb JC, Verma S, et al. Synopsis of the PI-RADS v2 guidelines for multiparametric prostate magnetic resonance imaging and recommendations for use. Eur Urol, 2016, 69(1): 41-49.
[10]
Hoda A, El-Kareem A, El-Samei, et al. Assessment of the accuracy of multi-parametric MRI with PI-RADS V2.0 scoring system in the discrimination of suspicious prostatic focal lesions. Egyptian J Radiol Nuclear Med, 2016, 47(3): 648-658.
[11]
Arnaldo S, Imbriaco M, Cocozza S, et al. Erratum to biparametric 3t magnetic resonance imaging for prostatic cancer detection in a biopsy-naïve patient population: A further improvement of PI-RADS V2. Eur J Radiol, 2016, 85(12): 2269-2274.
[12]
Rosenkrantz AB, Verma S, Choyke P, et al. Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: A consensus statement by AUA and SAR. J Urol, 2016, 196(6): 390-397.
[13]
李拔森,王良,闵祥德,等.第二版前列腺影像报告和数据系统对前列腺癌的诊断价值.放射学实践, 2016, 31(12): 1138-1142.

PREV Analysis of MRI signal characteristics of neonatal severe hyperbilirubinemia
NEXT Imaging feature of angiolipoma in sacrum: A case report
  



Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn